Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia

We present a case of a woman being treated for chronic myelocytic leukemia (CML) who developed eosinophilia without systemic involvement from imatinib mesylate (imatinib) confirmed by rechallenge with imatinib followed by eosinophilia recrudescence from dasatinib.

http://ift.tt/2qXnYhm